The most frequently mutated splicing factor in cancer, SF3B1, is mutated across both solid and hematologic malignancies (Chen et al., 2021; Bradley and Anczuków, 2023; Kahles et al., 2018) (Fig. 2 D). The gene discussed is SLU7; the disease is hematologic disorder.